Steinijans V W, Sauter R, Hauschke D, Diletti E, Schall R, Luus H G, Elze M, Blume H, Hoffmann C, Franke G
Department of Biometry, Byk Gulden Pharmaceuticals, Konstanz, Germany.
Int J Clin Pharmacol Ther. 1995 Aug;33(8):427-30.
Bioequivalence studies are usually performed as crossover studies and, therefore, information on the intrasubject coefficient of variation is needed for sample size planning. However, this information is usually not accessible in publications on bioequivalence studies, and only the pooled inter- and intrasubject coefficient of variation for either test or reference formulation is reported. It is the purpose of the present communication to provide reference values of the intrasubject coefficient of variation for various previously investigated drugs. The presentation includes pertinent pharmacokinetic characteristics for immediate- and extended-release formulations in single- and multiple-dose crossover studies.
生物等效性研究通常作为交叉研究进行,因此,样本量规划需要受试者内变异系数的信息。然而,在生物等效性研究的出版物中通常无法获得此信息,并且仅报告了受试制剂或参比制剂的合并受试者间和受试者内变异系数。本交流的目的是提供各种先前研究药物的受试者内变异系数的参考值。介绍内容包括单剂量和多剂量交叉研究中速释和缓释制剂的相关药代动力学特征。